IMMUNOEXPRESSION OF TWIST IN DIFFERENT MORPHOLOGICAL VARIANTS OF AMELOBLASTOMAS
AbstractBackground: Ameloblastoma is the most common and a clinically significant odontogenic tumour. The diagnosis and sub classification of ameloblastoma have been traditionally relied on histological assessment, but it is still a subject of debate. The aim of this study was to evaluate the immuno-expression of Twist in various subtypes of ameloblastomas and their co-relation with various histological variants. Methods: This cross-sectional study was conducted in the Department of Pathology, Post Graduate Medical Institute, Lahore between June to December 2013. Thirty cases of various types of Ameloblastomas were included in this study. Histological sub-classification of the tumours was performed based on WHO classification. Twist expression of these tumours was estimated by immunohistochemistry, performed on paraffin sections. Results: Out of these thirty cases, 22 (73%) were newly diagnosed typical solid/multicystic intraosseous ameloblastoma, 2 (7%) cases belonged to recurrent ameloblastoma, and 3 (10%) each were diagnosed as peripheral/extraosseous ameloblastoma and ameloblastic carcinoma. On histopathological sub-classification of the newly diagnosed solid ameloblastoma, 8 cases were diagnosed as follicular ameloblastoma in which 3 cases (37.5%) were negatively stained, 4 cases (50%) were mild positive and 1 case (12.5%) was moderate positive with Twist immunostaining. Out of 5 cases of plexiform ameloblastoma 3 cases (60%) were mild positive. Out of 4 cases of acanthomatous ameloblastoma 2 (50%) were moderate positive and 2 cases (50%) were strong positive. All granular cell ameloblastoma stained positive. The only case of desmoplastic ameloblastoma was moderately positive. Both the cases of recurrent ameloblastoma were strongly positive. All 3 cases of peripheral ameloblastoma stained negatively. All ameloblastic carcinoma were strongly positive. Conclusion: Twist immunohistochemical analysis can be used as an adjuvant to H&E histopathological findings for proper categorization and grading of ameloblastoma especially in the clinically aggressive tumours.Keywords: Ameloblastoma, Twist, gene,immunoexpression
Cawson RA, Odell EW. Cawson’s essential of oral pathology and oral medicine. 8th ed. Churchill Livingstone, Elsevier medical publisher, 2008;pp.136–55.
Ghom A, Mhaske S. Text book of Oral pathology. New dehli, Jaypees brother medical publishers, 2008 PP 280–318.
Weing BM. Atlas of Head and Neck Pathology.2nd ed. New york, Saunders: 2008;pp.113–38.
Ebenezer V, Ramalingam B. A cross-sectional survey of prevalence of odontogenic tumours. J Maxillofac Oral Surg 2010;9(4):369–73.
Shahidi SH, Bronooh P, Daneshood Y. Follicular ameloblastoma presenting as a sino nasal tumour. Iran Red Crescent Med J 2012;14(2):113–16.
Siar CH, Nagatsuka H, Chuah KS, Rivera RS, Nakano K, Ng KH, et al. Notch4 over expression in ameloblastoma correlates with the solid/multicystic phhenotype. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(2):224–33.
Sank JJ, Nikitakis NG, Scheper MA. Are we on the brink of non surgical treatment for ameloblastoma?. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;110(1):68–78.
Ngwenya SP, Raubenheimer EJ, Noffke CE. Internal morphology of ameloblastoma: a study of 24 resected specimens. Oral Surg Oral Med Oral sPathol Oral Radiol Endod 2009;108(5):754–62.
Gardner DG, Heihinheimo K, Shear M, Philipsen HP, Coleman H. Ameloblastomas. In: Barnes L, Eveson JW, Reichart PA, Sidransky D. eds. World Health Organization classification of tumors: Pathology and genetics of head and neck tumors, Lyons: IARC Press, 2005;pp.296–300.
Avon SL, Mccomb J, Clokie C. Ameloblastic Carcinoma: Case report and literature review. J Can Dent Assoc 2003;69(9):573–6.
Yoon HJ, Hong SP, Lee JI, Lee SS, Hong SD. Ameloblastic carcinoma: an analysis of 6 cases with review of literature. Oral surg oral med oral pathol oral radiol endod 2009;108(6):904–13.
Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. Twist, a master regulator of morphogenises, plays an essential role in tumour metastasis. Cell 2004;117(7):927–39.
Yuen HF, Kwok WK, Chan KK, Chua CW, Chan YP, Chu YY, et al. Twist modulates prostate cancer cell-mediated bone cell activity and is upregulated by osteogenic induction. Carcinogenisis 2008;29(8):1509–18.
Feng Y, Zhou YM, Hua CG, Tang XF, He DQ. Expression of Twist in different subtypes of ameloblastoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108(4):565–70.
Shiota M, Izumi H, Onitsuka T, Miyamota N, Kashiwagi E, kidani A, et al. Twist and P53 receprocally regulate target genes via direct interaction. Oncogene 2008;27(42): 5543–53.
Rapidis AD, Andressakis DD, Stavrianos SD, Faratzis G, Arnogiannaki-Liappi N, Lagogiannis GA, et al, Ameloblastomas of the jaws: Clinico Pathological Review of 11 patients. Eur J Surg Oncol 2004;30(9):998–1002.
Chaisuparat R, Yodsanga S, Montaner S, Jham BC. Activation of the Akt/m TOR pathway in Dentigerous cyst, Odontogenic Keratocysts and Ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;116(3):336–42.
Hertog D, Van der wall I. Ameloblastoma of the jaws: a critical reappricial based on a 40-years single institution experience. Oral Oncol 2010;46(1):61–4.
Ladeinide AL, Ogunlewe MO, Bamgbose BO, Adeyemo WL, Ajayi OF, Arotiba GT, et.al. Ameloblastoma: analyses of 207 cases in a Nigerian Teaching Hospital. Quinteness Int 2006;37(1):69–74.
Neveile BW, Damm GD, Allen CM, Bouqot JE. Oral and maxillofacial pathology. 3rd ed. Saunders, Elsevier medical publisher. 2009;pp.678–740.
Reichard PA, Philipsen HP, Sooner S. Ameloblastoma: biological profile of 3677 cases, Eur J Cancer B Oral Oncol 1995;31(2) : 86-99.
Rajendran, R. Sivapathsundharam. Shafer’s text book of Oral Pathology, 6th ed. Saunders, Elsevier medical publisher.2009; pp.254–308.